Bluestein R H & CO LLC Novartis Ag Transaction History

Bluestein R H & CO LLC

$1.61 Billion
Q3 2022

A detailed history of Bluestein R H & CO LLC transactions in Novartis Ag stock. As of the latest transaction made, Bluestein R H & CO LLC holds 7,600 shares of NVS stock, worth $807,576. This represents 0.04% of its overall portfolio holdings.

Number of Shares

7,600

Previous 8,100 6.17%

Holding current value

$807,576

Previous $685,000 15.62%

% of portfolio

0.04%

Previous 0.04%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $37,305 - $43,630	-500 Reduced 6.17%	7,600 $578,000
Q2 2022 Aug 11, 2022	SELL	$80.52 - $93.75 $161,040 - $187,500	-2,000 Reduced 19.8%	8,100 $685,000
Q2 2020 Aug 12, 2020	SELL	$80.93 - $91.1 $8,093 - $9,110	-100 Reduced 0.98%	10,100 $882,000
Q1 2020 May 12, 2020	BUY	$70.67 - $99.01 $2,826 - $3,960	40 Added 0.39%	10,200 $841,000
Q4 2019 Feb 13, 2020	SELL	$84.35 - $95.37 $13,496 - $15,259	-160 Reduced 1.55%	10,160 $962,000
Q2 2019 Aug 12, 2019	BUY	$75.4 - $92.8 $16,588 - $20,416	220 Added 2.18%	10,320 $942,000
Q4 2018 Feb 13, 2019	SELL	$73.66 - $82.02 $154,686 - $172,242	-2,100 Reduced 17.21%	10,100 $867,000
Q2 2018 Aug 10, 2018	SELL	$64.91 - $73.36 $90,874 - $102,704	-1,400 Reduced 10.29%	12,200 $922,000
Q1 2018 May 10, 2018	SELL	$70.39 - $84.15 $106,007 - $126,729	-1,506 Reduced 9.97%	13,600 $1.1 Million
Q4 2017 Feb 13, 2018	BUY	$72.33 - $77.64 $433 - $465	6 Added 0.04%	15,106 $1.27 Million
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $1.12 Million - $1.17 Million	15,100	15,100 $1.3 Million

Others Institutions Holding NVS

# of Institutions

1,439

Shares Held

135M

Call Options Held

1.12M

Put Options Held

1.82M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $229B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bluestein R H & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bluestein R H & CO LLC with notifications on news.

Account

Bluestein R H & CO LLC Novartis Ag Transaction History